Webster Brian Daniel 4
4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed Mar 19, 2026
Research Summary
AI-generated summary of this filing
Kestra Medical (KMTS) CEO Brian Webster Sells 15,000 Shares
What Happened Brian Daniel Webster, President, Chief Executive Officer and a director of Kestra Medical Technologies, Ltd. (KMTS), sold 15,000 shares on March 17, 2026 in an open-market transaction. The reported weighted-average price was $20.27 per share for a total value of $304,124. The prices in the sale ranged from $20.00 to $20.7709.
Key Details
- Transaction date: March 17, 2026; Form 4 filed March 19, 2026 (within the typical 2-business-day filing window).
- Transaction type: Sale (code S); 15,000 shares disposed.
- Price: Weighted average $20.27; individual sale prices ranged $20.00–$20.7709. The filer notes they can provide a breakdown of shares sold at each price on request.
- Footnote: Sale occurred pursuant to a Rule 10b5-1 trading plan adopted September 29, 2025 (preplanned trades).
- Shares owned after the transaction: Not specified in the provided filing.
Context This was a sale under a pre-established 10b5-1 plan, which typically indicates the trades were prearranged rather than timed based on inside information. Sales are often routine and do not by themselves signal the insider’s view of the company; purchases generally carry more weight for bullish interpretation.
Insider Transaction Report
- Sale
Common Shares
[F1][F2]2026-03-17$20.27/sh−15,000$304,124→ 364,786 total
Footnotes (2)
- [F1]The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
- [F2]The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $20.0000 to $20.7709. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.